コンテンツへスキップ
Merck
  • A simple protocol to produce mature human-induced pluripotent stem cell-derived cardiomyocytes.

A simple protocol to produce mature human-induced pluripotent stem cell-derived cardiomyocytes.

STAR protocols (2021-11-11)
Walter E Knight, Yingqiong Cao, Phoebe Dillon, Kunhua Song
要旨

When cultured under typical conditions, human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are structurally and functionally immature. We have previously demonstrated that culture of hiPSC-CMs in maturation medium containing fatty acids, in combination with culture on micropatterned surfaces, produces cells that demonstrate a more mature phenotype compared to standard approaches. Here, we show in detail the steps needed to produce mature hiPSC-CMs. Compared with many approaches, our protocol is relatively simple and can be easily adapted to new laboratories. For complete details on the use and execution of this protocol, please refer to Knight et al. (2021).

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
プロテアーゼインヒビターカクテル, for use with mammalian cell and tissue extracts, DMSO solution
Sigma-Aldrich
スクロース, for molecular biology, ≥99.5% (GC)
Sigma-Aldrich
MOPS, ≥99.5% (titration)
Sigma-Aldrich
ゼラチン from porcine skin, gel strength 300, Type A
Sigma-Aldrich
モノクロナール抗α-アクチニン (筋節) マウス宿主抗体, clone EA-53, ascites fluid
Sigma-Aldrich
Triton X-100, laboratory grade
Sigma-Aldrich
水酸化カリウム, BioXtra, ≥85% KOH basis
Millipore
EDTA, ULTROL® Grade, 500 mM Solution, pH 8.0
Sigma-Aldrich
尿素, ACS reagent, 99.0-100.5%
Sigma-Aldrich
エチレングリコール-ビス(2-アミノエチルエーテル)-N,N,N′,N′-四酢酸, ≥97.0%